Thompson Davis & Co’s Rockwell Medical RMTI Stock Holding History

Thompson Davis & Co’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2	Closed	-$2K	–	1180
2017 Q2	$2K	Buy	+2	New	+$1.64K	﹤0.01%	999
2016 Q3	–	Sell	-2	Closed	-$2K	–	1162
2016 Q2	$2K	Buy	+2	New	+$1.86K	﹤0.01%	966
2016 Q1	–	Sell	-36	Closed	-$41K	–	1149
2015 Q4	$41K	Buy	+36	New	+$41.9K	0.06%	290
2015 Q3	–	Sell	-95	Closed	-$169K	–	1227
2015 Q2	$169K	Buy	+95	New	+$121K	0.19%	118
2014 Q3	–	Sell	-9	Closed	-$12K	–	1217
2014 Q2	$12K	Hold	9	–	–	0.02%	464
2014 Q1	$13K	Buy	9 +2	+29%	+$2.6K	0.02%	453
2013 Q4	$8K	Buy	+7	New	+$9.65K	0.01%	498

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return

Thompson Davis & Co's RMTI Position: Q3 2017 in Review

Thompson Davis & Co sold out of Rockwell Medical (RMTI) in Q3 2017, closing a stake of 2 shares — an estimated $2K sold.

Thompson Davis & Co first reported a position in RMTI in Q4 2013 and held it in 7 quarters. The position peaked at $169K in Q2 2015. 84 funds tracked by Wall St. Rank hold RMTI as of Q3 2017.

Thompson Davis & Co reported no remaining Rockwell Medical position as of Q3 2017 after selling out during the quarter.
Thompson Davis & Co sold 2 Rockwell Medical shares in Q3 2017, an estimated $2K.
Thompson Davis & Co first reported a position in Rockwell Medical in Q4 2013 and held it in 7 quarters.
Thompson Davis & Co's Rockwell Medical position peaked at $169K in Q2 2015.
84 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2017.

Based on Thompson Davis & Co's 13F filing for Q3 2017, filed 30 Oct 2017.